# Rocuronium vs Cis-atracurium: Do Rocuronium Still 'ROCKS' In Coronary Artery Bypass Grafting

> **NCT06102915** · — · COMPLETED · sponsor: **Institut Jantung Negara** · enrollment: 289 (actual)

## Conditions studied

- Neuromuscular Blockade
- Postoperative Pulmonary Atelectasis
- Postoperative Pulmonary Complication
- Coronary Artery Disease
- Coronary Artery Bypass Grafting
- Hypothermic Cardiopulmonary Bypass

## Interventions

- **DRUG:** Rocuronium Bromide 10 MG/ML
- **DRUG:** Nimbex 10 MG in 5 ML Injection

## Key facts

- **NCT ID:** NCT06102915
- **Lead sponsor:** Institut Jantung Negara
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-01
- **Primary completion:** 2023-11-23
- **Final completion:** 2023-11-23
- **Target enrollment:** 289 (ACTUAL)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06102915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06102915, "Rocuronium vs Cis-atracurium: Do Rocuronium Still 'ROCKS' In Coronary Artery Bypass Grafting". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06102915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*